These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 17725455)

  • 21. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.
    Davenport A;
    J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A; Weisz M; Kathuria P
    Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of exit-site care and catheter design on the incidence of catheter-related infections.
    Jones LL; Tweedy L; Warady BA
    Adv Perit Dial; 1995; 11():302-5. PubMed ID: 8534730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exit-site infections by non-diphtheria corynebacteria in CAPD.
    Schiffl H; Mücke C; Lang SM
    Perit Dial Int; 2004; 24(5):454-9. PubMed ID: 15490985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system.
    Ghahramani N; Gorban-Brennan N; Kliger AS; Finkelstein FO
    Adv Perit Dial; 1995; 11():164-7. PubMed ID: 8534695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
    Cho KH; DO JY; Park JW; Yoon KW
    Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
    Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
    Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
    Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
    Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients.
    Gadallah MF; Tamayo A; Sandborn M; Ramdeen G; Moles K
    Adv Perit Dial; 2000; 16():233-6. PubMed ID: 11045301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
    Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
    Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD).
    Bernardini J; Holley JL; Johnston JR; Perlmutter JA; Piraino B
    Clin Nephrol; 1991 Jul; 36(1):29-34. PubMed ID: 1889148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.
    Luzar MA; Coles GA; Faller B; Slingeneyer A; Dah GD; Briat C; Wone C; Knefati Y; Kessler M; Peluso F
    N Engl J Med; 1990 Feb; 322(8):505-9. PubMed ID: 2300122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritonitis with multiple rare environmental bacteria in a patient receiving long-term peritoneal dialysis.
    Levitski-Heikkila TV; Ullian ME
    Am J Kidney Dis; 2005 Dec; 46(6):e119-24. PubMed ID: 16310563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey.
    Kopriva-Altfahrt G; König P; Mündle M; Prischl F; Roob JM; Wiesholzer M; Vychytil A; ; Arneitz K; Karner A; Artes R; Wolf E; Auinger M; Pawlak A; Fraberger J; Hofbauer S; Galvan G; Salmhofer H; Pichler B; Wazel M; Gruber M; Thonhofer A; Hager A; Malajner S; Heiss S; Braunsteiner T; Zweiffler M; König P; Rudnicki M; Kogler R; Kohlhauser D; Wiesinger T; Kopriva-Altfahrt G; Moser E; Kotanko P; Loibner H; Nitz H; Miska HJ; Wenzel R; Wölfer M; Mündle M; Breuss H; Hölzl B; Prischi F; Schmekal B; Riener EM; Roob JM; Wonisch W; Vikydal R; Vychytil A; Frank B; Wieser C; Wiesholzer M; Pokorny K
    Perit Dial Int; 2009; 29(3):330-9. PubMed ID: 19458307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
    Wong SS; Chu KH; Cheuk A; Tsang WK; Fung SK; Chan HW; Tong MK
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.
    Pommer W; Brauner M; Westphale HJ; Brunkhorst R; Krämer R; Bundschu D; Höffken B; Steinhauer HB; Schümann E; Lüttgen FM; Schillinger-Pokorny E; Schaefer F; Wende R; Offner G; Näther S; Osten B; Zimmering M; Ehrich JH; Kehn M; Mansmann U; Grosse-Siestrup C
    Am J Kidney Dis; 1998 Nov; 32(5):752-60. PubMed ID: 9820444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
    Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
    Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.